xmlui.ArtifactBrowser.ConfigurableBrowse.title.metadata.subject_decs
Ara mostrant els elements 1-20 d 131
-
30-Day Mortality Following Palliative Radiotherapy
(Frontiers Media, 2021-04-23) -
A Phase I Dose-Escalation Study of LY3405105, a Covalent Inhibitor of Cyclin-Dependent Kinase 7, Administered to Patients With Advanced Solid Tumors
(Oxford University Press, 2024-01) -
A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors
(American Association for Cancer Research, 2022-06-01) -
A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer
(American Association for Cancer Research, 2023-01-17) -
A whirl of radiomics-based biomarkers in cancer immunotherapy, why is large scale validation still lacking?
(Nature Portfolio, 2024-02-21) -
Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation
(Nature Research, 2021-02-23) -
Allelic Frequency of DPYD Genetic Variants in Patients With Cancer in Spain: The PhotoDPYD Study
(Oxford University Press, 2023-05) -
Anti-TIGIT Antibody Tiragolumab Alone or With Atezolizumab in Patients With Advanced Solid Tumors: A Phase 1a/1b Nonrandomized Controlled Trial
(American Medical Association, 2023-11) -
Antitumor Activity and Safety of Dostarlimab Monotherapy in Patients With Mismatch Repair Deficient Solid Tumors: A Nonrandomized Controlled Trial
(American Medical Association, 2023-11) -
Cabozantinib combination therapy for the treatment of solid tumors: a systematic review
(SAGE Publications, 2022)